According to the currently used nomenclature, there are only two types of hepatocellular nodular lesions: regenerative lesions and dysplastic or neoplastic lesions. Regenerative nodules include monoacinar regenerative nodules, multiacinar regenerative nodules, cirrhotic nodules, segmental or lobar hyperplasia, and focal nodular hyperplasia. Dysplastic or neoplastic nodules include hepatocellular adenoma, dysplastic foci, dysplastic nodules, and hepatocellular carcinoma (HCC). Many of these types of hepatic nodules play a role in the de novo and stepwise carcinogenesis of HCC, which comprises the following steps: regenerative nodule, low-grade dysplastic nodule, high-grade dysplastic nodule, small HCC, and large HCC. State-of-the-art magnetic resonance (MR) imaging facilitates detection and characterization in most cases of hepatic nodules. State-of-the-art MR imaging includes single-shot fast spin-echo imaging, in-phase and opposed-phase T1-weighted gradient-echo imaging, T2-weighted fast spin-echo imaging with fat saturation, and two-dimensional or three-dimensional dynamic multiphase contrast material-enhanced imaging. 
Introduction
Various parenchymal liver diseases may lead to hepatitis, fibrosis, and eventually cirrhosis. Cirrhotic liver contains regenerative nodules and may also contain dysplastic nodules as well as hepatocellular carcinoma (HCC) (1) . By understanding the transition from benign through dysplastic to malignant nodules, one can more easily make sense of the complex nodularity depicted in cirrhotic livers with multiple magnetic resonance (MR) imaging pulse sequences (2) (3) (4) .
During the past 2 decades, MR imaging has emerged as an important imaging modality for assessing cirrhosis and its complications, such as hepatic nodules (1) . For assessment of hepatic nodules, MR imaging is more useful than any other imaging modality currently available (1) .
The state-of-the-art MR imaging technique at our institution includes single-shot fast spin-echo images with shorter and longer echo times, inphase and opposed-phase T1-weighted gradientecho images, T2-weighted fast spin-echo images with fat suppression, a timing-bolus sequence, and two-dimensional or three-dimensional thinsection dynamic multiphasic gadolinium-enhanced images. The single-shot images serve as (a) localizers and (b) sequences for characterizing lesions (solid vs nonsolid) on the basis of the echo time. The in-phase and opposed-phase images can be used to detect focal or diffuse abnormalities. The T2-weighted fast spin-echo sequence with fat suppression is a very sensitive sequence for focal liver lesions. The timing-bolus sequence allows more reliable imaging of the liver in the arterial phase, which is crucial for detection of hypervascular liver lesions, such as adenomas, focal nodular hyperplasia (FNH), and HCC. The multiphasic dynamic sequences show the enhancement patterns of liver lesions, which are very helpful in characterization of the lesions. In addition, MR imaging with tissue-specific contrast media can be advocated to answer certain questions that might remain after MR imaging with gadolinium contrast material (eg, if the results of the gadolinium-enhanced MR imaging study are not conclusive concerning the hepatocellular origin of the tumor).
This article describes and illustrates current concepts about hepatic nodules. Specific topics discussed are etiologic factors, currently used terminology, pathways of carcinogenesis, histopathologic features, and MR imaging features.
Etiologic Factors
Except for FNH, hepatic nodules usually develop in previously damaged livers. Damage to the liver can be caused by several factors (5,6):
1. Endemic: Aflatoxin, a product of the fungus Aspergillus flavus, which grows on improperly stored grain and nuts (including peanuts), is considered an important cause of HCC in Africa and Asia.
2. Metabolic and genetic disorders, including hemochromatosis (increased hepatocellular iron deposition), Wilson disease (increased hepatocellular copper deposition), and ␣ 1 -antitrypsin deficiency, can lead to cirrhosis, hepatic nodules, and HCC.
3. Dietary: Obesity, diabetes (type II), as well as alcoholism can lead to fatty infiltration of the liver (steatosis), steatohepatitis, and cirrhosis.
4. Viral: Viral hepatitis, mainly caused by the hepatitis B and hepatitis C viruses, is currently the most important etiologic factor leading to liver fibrosis and cirrhosis in North America.
Currently Used Terminology
Since 1995, a modified nomenclature has categorized hepatic nodules into two groups: regenerative lesions and dysplastic or neoplastic lesions (7) .
Regenerative nodules result from localized proliferation of hepatocytes and their supporting stroma. Regenerative lesions include monoacinar regenerative nodules, multiacinar regenerative nodules, cirrhotic nodules, segmental or lobar hyperplasia, and FNH.
A monoacinar or multiacinar regenerative nodule is a well-defined region of parenchyma that has enlarged in response to necrosis, altered circulation, or other stimuli. It may contain one (monoacinar) or multiple (multiacinar) portal tracts. The diameter of monoacinar nodules is usually 0.1-10 mm, and that of multiacinar nodules should be at least 2 mm. Large multiacinar nodules are usually 5-15 mm in diameter. Cirrhotic nodules are regenerative nodules that are largely or completely surrounded by fibrous septa. Cirrhotic nodules can be mono-or multiacinar. Macronodular cirrhosis contains nodules larger than 3 mm in diameter (7) .
Dysplastic or neoplastic lesions are composed of hepatocytes that show histologic characteristics of abnormal growth caused by a presumed or proved genetic alteration. Dysplastic or neoplastic nodules include hepatocellular adenoma, dysplastic foci, dysplastic nodules, and HCC.
A dysplastic focus is defined as a cluster of hepatocytes less than 1 mm in diameter with dysplasia but without definite histologic criteria for malignancy. Dysplasia indicates the presence of nuclear and cytoplasmic changes, such as minimal to severe nuclear atypia and an increased amount of cytoplasmic fat or glycogen, within the cluster of cells that compose the focus. Dysplastic foci are common in cirrhosis and uncommon in noncirrhotic livers. The dysplasia can be of the small or large cell type (7) .
A dysplastic nodule is a nodular region of hepatocytes at least 1 mm in diameter with dysplasia but without definite histologic criteria for malignancy. These nodules are usually found in cirrhotic livers. Dysplastic nodules can be low grade or high grade (7). Nodules with low-grade dysplasia may show an altered liver parenchymal structure as well as an increased number of cells with an increased nuclei-to-cytoplasm ratio. Nodules with high-grade dysplasia show increased thickness of the layers of hepatocytes, which contain nuclei that are variable in size and shape.
HCC is a malignant neoplasm composed of cells with hepatocellular differentiation. A small HCC is defined as less than or equal to 2 cm in diameter. The criteria used to distinguish HCC from high-grade dysplastic nodules are not clearly defined. Criteria in favor of malignancy include (a) prominent nuclear atypia; (b) a high nuclearcytoplasmic ratio with nuclear density twice as great as normal; (c) plates three or more cells thick, numerous unaccompanied arteries; (d) mitoses in moderate numbers; and (e) invasion of the stroma or portal tracts. Most small HCCs cannot be distinguished histologically from dysplastic nodules with certainty. In addition, foci of carcinoma can be found in otherwise benign dysplastic nodules. These and other findings support the theory of stepwise carcinogenesis of HCC (7).
Pathways of Carcinogenesis
A stepwise carcinogenesis for HCC has been proposed on the basis of gradually increasing size and cellular density among the following lesions: regenerative nodules, adenomatous hyperplasia, atypical adenomatous hyperplasia, early HCC, and early advanced HCC (8, 9) . According to the currently used terminology, the stepwise sequence of events (regenerative nodule to adenomatous hyperplasia to atypical adenomatous hyperplasia to early HCC to early advanced HCC) can be translated as follows: regenerative nodule, low-grade dysplastic nodule, high-grade dysplastic nodule, small HCC, and large HCC (Fig 1) . Several authors have proposed a de novo pathway for HCC in cirrhotic as well as noncirrhotic livers (1, 8, 9) . According to the de novo pathway, a single cell or a group of hepatocytes may give rise to a focus of small HCC that will grow into a large HCC (1) .
At some point during the whole process of carcinogenesis for HCC (most likely when regenerative nodules become dysplastic nodules), formation of new tumor vessels (tumor angiogenesis, neovascularity) takes place (1) . The appearance Stepwise pathway of carcinogenesis for HCC in cirrhosis. One or more regenerative nodules may show signs of atypia (⅙) and change into dysplastic nodules. Atypia indicates a number of changes in the shape and size of the nuclei and the cytoplasm of the hepatocytes. These changes often result in an increased number of cells (increased cellularity), which may be present in groups of small cells (small cell dysplasia) or large cells (large cell dysplasia). Atypia within dysplastic nodules can progress further and give rise to small and large HCCs. In addition to the cellular changes, the hepatic parenchymal structure will often be distorted in HCC. (Adapted and reprinted, with permission, from reference 1.) of new tumor vessels is important in the transformation of regenerative nodules into dysplastic nodules and small HCCs. Neoangiogenesis is also important for sustained growth of HCC. In addition, neovascularity within HCC can be used for early detection and characterization of these lesions with imaging.
Histopathologic Features
The histologic grade of tumor differentiation is assigned by using the Edmondson grading system (10, 11) . At histologic analysis, it may be difficult to differentiate among hepatocellular nodules (Fig 2) . Depending on tumor differentiation, one hepatocellular lesion may contain one or more clonelike cell populations, and these cell populations can be graded from I to IV. Grade I consists of cells that are similar in size to normal hepatocytes and arranged in relatively thin trabeculae. Acini containing bile are rare. Grade II consists of cells that are larger than normal hepatocytes with more hyperchromatic nuclei, which occupy a higher proportion of cells. The trabeculae are thicker, and acini with bile are common. Grade III consists of hepatocytes with larger nuclei, occupying more than 50% of the cytoplasm. The trabeculae are still dominant, but solid areas and isolated cells may also be present. In addition, giant and bizarre cells are common. Bile is rarely present. Grade IV consists of cells with nuclei occupying most of the cytoplasm, and the cytoplasm may not be eosinophilic. Mostly solid areas are found. Bile is rarely found. Intravascular and intrasinusoidal growth is commonly present. With this grading system, grade I cell populations may be difficult to distinguish from hepatocellular adenomas, and grade IV cell populations may be difficult to distinguish from tumors of nonhepatocellular origin (10) .
The classic macroscopic classification of HCC by Eggle has been used since 1901. According to this classification, Edmondson and Steiner (10) categorized 70 HCCs in their series as nodular (81%), massive (23%), and diffuse (3%). This classification is mainly based on autopsy cases of HCC. Compared with the massive lesions, the nodular tumors are smaller and more distinct with sharper margins to the liver (10). The massive lesions are either composed of confluent smaller tumors or consist of predominantly one large lesion that often occupies almost the entire liver. The diffuse lesions consist of multiple infiltrating lesions that occupy a large part of the liver (10).
MR Imaging Features Focal Nodular Hyperplasia
FNH is a benign liver tumor that occurs predominantly in women during their reproductive years, but cases have been reported in men and children (12) (13) (14) . FNH is lobulated and well circumscribed, although unencapsulated (13) . The pathognomonic macroscopic feature is a central stellate scar with radiating septa, thereby dividing the lesion into numerous nodules of normal hepatocytes that are abnormally arranged (13, 15) . The central scar contains thick-walled vessels with sources from the hepatic artery, which provides excellent arterial blood supply to the lesion (16) . The most characteristic microscopic features of FNH are the fibrous septa and the areas of hepatocellular proliferation (15) . The nodules within FNH lack normal central veins and portal tracts. The bile ducts seen within the central scar do not connect to the biliary tree (15) . According to the International Working Party (7), FNH is considered a regenerative benign nodule. FNH is often an incidental finding at imaging studies and needs to be differentiated from other focal liver lesions such as HCC, hepatocellular adenoma, and hypervascular metastases (1, 17) . Most cases of FNH do not need treatment (17) .
At MR imaging, FNH is slightly hypointense on T1-weighted images and slightly hyperintense on T2-weighted images (6) . FNH may also be nearly isointense on both T1-and T2-weighted images (6) . Unlike liver cell adenomas, FNH rarely has higher signal intensity than the liver on T1-weighted images (1, 6) . The central scar usually has high signal intensity on T2-weighted images (14) . FNH shows very intense homogeneous enhancement during the arterial phase of a H-E stain) shows normally arranged hepatocytes (straight arrow) and a fibrous septum (curved arrow) containing biliary structures (ૺ). These findings are compatible with the diagnosis of FNH. (c) Photomicrograph of hepatocellular adenoma (original magnification, ϫ400; H-E stain) shows more or less normal hepatocytes arranged in one-or two-cell layers (arrow). The tumor did not contain any fibrous septa or biliary structures. This combination of findings is typical of hepatocellular adenoma at histopathologic analysis. (d) Photomicrograph of two neighboring regenerative nodules (original magnification, ϫ200; H-E stain) that are separated by a septum (curved arrow) shows an altered hepatic parenchymal structure, as well as an increased number of cells with small cell dysplasia and nuclear crowding in one nodule (black straight arrow) and large cell dysplasia consisting of larger hepatocytes with larger nuclei in the other nodule (white arrow). The findings are compatible with low-grade dysplasia. (e) Photomicrograph of high-grade dysplasia (original magnification, ϫ200; H-E stain) shows increased thickness of the layers of hepatocytes, which contain nuclei that are variable in size and shape (arrows). (f) Photomicrograph of HCC (original magnification, ϫ400; H-E stain) shows large polymorphous hepatocytes arranged in thick layers (straight arrows). Note the large number of vascular structures containing erythrocytes (curved arrow), which indicate tumor angiogenesis. (1,6,14) . The central scar and the radiating septa show enhancement on delayed images (Fig 3) (14) .
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Hepatocellular Adenoma
Liver adenomas typically occur in young women using oral contraceptives (6) . These tumors were rarely reported in the medical literature before the introduction of oral contraceptives in the early 1960s. An association with other conditions or hepatocellular stimulating agents, such as familial diabetes mellitus, galactosemia, glycogen storage disease type 1, and anabolic steroids, has been reported (6) . Liver cell adenomas are composed of sheets of cells that may resemble normal hepatocytes (7, 17, 18) . Unlike FNH, liver cell adeno- mas lack a central scar and radiating septa. Necrosis and hemorrhage are frequent causes of pain (6) . In addition, according to the currently used terminology, hepatocellular adenomas are classified as premalignant nodules (7). Owing to their potential for hemorrhage and malignant degeneration, hepatocellular adenomas are preferably treated surgically (17) .
At MR imaging, liver adenomas typically do not differ much in signal intensity from the surrounding liver parenchyma on T1-and T2-weighted images. The lesions are mildly hypointense to moderately hyperintense on T1-weighted images and mildly hyperintense on T2-weighted images (6) . They show a blush of homogeneous enhancement in the arterial phase and become nearly isointense in later phases of dynamic gadolinium-enhanced imaging (Fig 4) . 
Regenerative Nodules, Dysplastic Nodules, and HCC
Typically, regenerative nodules show low signal intensity on T2-weighted images, variable signal intensity on T1-weighted images, and no enhancement on arterial phase dynamic gadolinium-enhanced images (Fig 5) (1,19 -21 ).
HCC is a focal liver lesion with high signal intensity on T2-weighted images and variable signal intensity on T1-weighted images; it shows intense enhancement during the arterial phase of dynamic gadolinium-enhanced imaging (Fig 6)  (1,19,20,22 ). (original magnification, ϫ100; H-E stain) shows a regenerative nodule surrounded by septa (curved arrow), which contain a number of portal vein tracts (straight arrows).
The signal intensity and enhancement characteristics of dysplastic nodules are not yet well established. Owing to a gradual stepwise transition from a regenerative nodule to a low-grade dysplastic nodule, a high-grade dysplastic nodule, and eventually to a small HCC and a large HCC, the hepatocytes within hepatic nodules undergo numerous changes that might not be reflected in their signal intensity or vascularity. Thus, current MR imaging sequences might not allow differentiation of regenerative nodules from dysplastic nodules with certainty. Some MR imaging features of high-grade dysplastic nodules and small HCC have been described (1,2,19 -21) . A majority of high-grade dysplastic lesions (formerly known as adenomatous hyperplasia) and well-differentiated small HCCs (Edmondson grade I or II) have high signal intensity on T1-weighted images (Fig 6) (19 -21) .
Small HCC
Recent MR imaging techniques allow thinner sections with higher matrices in combination with high intrinsic soft-tissue contrast. In addition, faster imaging sequences allow imaging with sufficiently higher temporal resolution to capture the distinct arterial and other phases of enhancement of liver lesions during gadolinium-enhanced imaging (1). This facilitates detection of smaller HCCs (2) . The definition of small tumors has changed, from a solitary lesion less than 4.5 cm in diameter to a tumor less than or equal to 2 cm in diameter (2) .
High-grade dysplastic nodules and small HCC may have a nodule-within-a-nodule appearance on MR images, especially if a focus of HCC originates within a siderotic regenerative nodule (23) . On T2-weighted images, this appearance may consist of low signal intensity of a large nodule, with one or more internal foci of higher signal intensity. On T1-weighted gradient-echo images, such lesions typically show markedly low signal intensity of a large nodule, with internal foci that are isointense to the liver. At MR imaging, the recognition of HCC while still small is important because the tumor is aggressive and has a fast doubling time (24) . Small HCC may also appear as small areas of slightly higher signal intensity than the surrounding liver on T2-weighted images. On T1-weighted images, such areas may be isointense, hypointense, or hyperintense to the liver. On arterial phase dynamic gadolinium-enhanced images, most small HCCs show intense enhancement (Fig 7) . The MR imaging appearance of such areas suggests a replacing, instead of an expanding, type of growth (11) .
Large HCC
Large HCC may have a number of characteristic features, such as a mosaic pattern, a tumor capsule, extracapsular extension with formation of satellite nodules, vascular invasion, and extrahepatic dissemination, including lymph node and distant metastases (1).
The mosaic pattern is a configuration of confluent small nodules separated by thin septa and necrotic areas within the tumor. This appearance most likely reflects the histopathologic features as well as the characteristic growth pattern of HCC. In one study, 88% of lesions with a mosaic pattern were larger than 2 cm in diameter (25) . The mosaic pattern is more often depicted on T2-weighted images than on T1-weighted images (25) . On T1-and T2-weighted images, the mosaic pattern appears as areas of variable signal intensities, whereas on gadolinium-enhanced images, the lesions enhance in a heterogeneous fashion during the arterial and later phases (25) . The degree of histologic differentiation, the presence of copper protein, and fatty infiltration may all be responsible for the mosaic pattern (Fig 8) . H-E stain) shows the HCC surrounded by the fibrous capsule (straight arrow). Owing to fatty infiltration, part of the tumor (curved arrow) appears more whitish than the other part of the lesion (ૺ). These findings reflect the mosaic appearance of the encapsulated lesion at MR imaging.
A tumor capsule, a characteristic sign of large HCC, is present in 60%-82% of cases (25) (Fig  8) . In one study, 56 of 72 HCCs showed a capsule at histologic analysis, and 75% of the lesions with a capsule were larger than 2 cm in diameter (25) . The tumor capsule becomes thicker with increasing tumor size (25) . At histologic analysis, capsules are composed of two layers, an inner fibrous layer and an outer layer containing compressed vessels and bile ducts (25) . The tumor capsule is hypointense on both T1-and T2-weighted images in most cases, although capsules with a thickness of more than 4 mm can have an outer hyperintense layer on T2-weighted images. Extracapsular extension of the tumor, with partial projections or formation of satellite nodules in the immediate vicinity, is present in 43%-77% of HCCs (1, 26) (Fig 9) .
Vascular invasion occurs frequently in HCC and can affect both the portal vein as well as the hepatic veins (1) . In a recent study of 322 patients undergoing curative resection of HCC, 15.5% had macroscopic venous invasion and 59.0% had microscopic venous invasion at histopathologic analysis (27) . In a meta-analysis of seven studies of 1,497 patients, portal vein invasion was found in 24% of cases of HCC (28) . At MR imaging, vascular invasion can be seen as lack of a signal void on multisection T1-weighted gradient-echo and flow-compensated T2-weighted fast spinecho images (1). On gadolinium-enhanced images, the tumor thrombus typically shows enhancement on images acquired during the arterial phase and a filling defect on images acquired during later phases (Fig 9) .
HCC in a Noncirrhotic Liver
In patients without cirrhosis or other underlying liver disease, HCC is usually diagnosed at a very late stage (29) . In one study of HCC in the noncirrhotic liver, the medium tumor diameter was 8.8 cm (30) . In a recent study of 36 patients with HCC, including 11 with and 25 without cirrhosis, the MR imaging appearance was compared (31) . The lesions in noncirrhotic livers were significantly larger, were more often solitary, and more frequently contained a central scar (Fig 10) (31) . Fibrolamellar carcinoma is a malignant hepatocellular tumor with distinct clinical and pathologic differences from conventional HCC (32) . Therefore, fibrolamellar carcinoma should be considered a separate entity. Cirrhosis, hepatitis, ␣-fetoprotein, or other typical risk factors for HCC are usually absent (33) . At histologic analysis, the lesions consist of large eosinophilic, polygonal neoplastic cells arranged in sheets, cords, or trabeculae separated by parallel sheets of fibrous tissue (ie, lamellae) (33) . Vascular invasion occurs in less than 5% of cases. Regional adenopathy may be present in 50%-70% of patients, and distant metastases are uncommon (20%) (33) . At MR imaging, fibrolamellar carcinomas are typically hypointense on T1-weighted images and hyperintense on T2-weighted images (33).
Discussion and Conclusions
Cirrhotic and noncirrhotic livers may contain a number of benign, premalignant, and malignant hepatocellular nodules. Recently, new terminology for hepatocellular lesions has been introduced. In particular, during the past 2 decades, MR imaging has increasingly been applied for evaluation of liver lesions. In many centers, MR imaging has become the modality of choice for assessment of cirrhotic and noncirrhotic liver lesions.
To familiarize readers with the recent developments, this article provides the relevant clinical background information and describes MR imaging features of hepatic nodules with pathologic correlation. State-of-the-art MR imaging with a number of T1-and T2-weighted and multiphasic dynamic contrast-enhanced sequences facilitates detection and characterization of the majority of hepatic nodules, including regenerative nodules, dysplastic nodules, HCC, hepatocellular adenoma, and FNH. After reading this article, the reader will understand the new classification of hepatocellular nodules, the carcinogenesis of HCC, and the typical MR imaging features of hepatic nodules. 
